Cargando…

Sodium glucose co-transporter 2 (SGLT2) inhibition via dapagliflozin improves diabetic kidney disease (DKD) over time associatied with increasing effect on the gut microbiota in db/db mice

BACKGROUND: The intestinal microbiota disorder gradually aggravates during the progression of diabetes. Dapagliflozin (DAPA) can improve diabetes and diabetic kidney disease(DKD). However, whether the gut microbiota plays a role in the protection of DAPA for DKD remains unclear. METHODS: To investig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Jiajia, Chen, Yan, Yang, Huinan, Gu, Leyi, Ni, Zhaohui, Mou, Shan, Shen, Jianxiao, Che, Xiajing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9908601/ https://www.ncbi.nlm.nih.gov/pubmed/36777358 http://dx.doi.org/10.3389/fendo.2023.1026040

Ejemplares similares

Dapagliflozin protects against nonalcoholic steatohepatitis in db/db mice
por: Qiao, Panshuang, et al.
Publicado: (2022)

Sottsass associati
Publicado: (1988)

Long-Term Treatment with the Sodium Glucose Cotransporter 2 Inhibitor, Dapagliflozin, Ameliorates Glucose Homeostasis and Diabetic Nephropathy in db/db Mice
por: Terami, Naoto, et al.
Publicado: (2014)

Dapagliflozin alleviates renal inflammation and protects against diabetic kidney diseases, both dependent and independent of blood glucose levels
por: Cai, Anxiang, et al.
Publicado: (2023)

Butyrate attenuated fat gain through gut microbiota modulation in db/db mice following dapagliflozin treatment
por: Oh, Tae Jung, et al.
Publicado: (2019)

Chlorogenic acid improves glucose tolerance, lipid metabolism, inflammation and microbiota composition in diabetic db/db mice
por: Yan, Yongwang, et al.
Publicado: (2022)

Long-Term Oral Administration of Salidroside Alleviates Diabetic Retinopathy in db/db Mice
por: Yao, Fei, et al.
Publicado: (2022)

Hepatic overexpression of protein targeting to glycogen attenuates obesity and improves hyperglycemia in db/db mice
por: López-Soldado, Iliana, et al.
Publicado: (2022)

A Comparative Peptidomic Characterization of Cultured Skeletal Muscle Tissues Derived From db/db Mice
por: Wu, Yanting, et al.
Publicado: (2019)

Extracellular lipidome change by an SGLT2 inhibitor, luseogliflozin, contributes to prevent skeletal muscle atrophy in db/db mice
por: Bamba, Ryo, et al.
Publicado: (2021)

Antidiabetic Effect of Artemether in Db/Db Mice Involves Regulation of AMPK and PI3K/Akt Pathways
por: Bai, Xiaolin, et al.
Publicado: (2020)

ATP-citrate lyase inhibitor improves ectopic lipid accumulation in the kidney in a db/db mouse model
por: Zhan, Zishun, et al.
Publicado: (2022)

Gut Microbiota Changes by an SGLT2 Inhibitor, Luseogliflozin, Alters Metabolites Compared with Those in a Low Carbohydrate Diet in db/db Mice
por: Hata, Shinnosuke, et al.
Publicado: (2022)

“Adjust Zang and arouse spirit” electroacupuncture ameliorates cognitive impairment by reducing endoplasmic reticulum stress in db/db mice
por: Li, Mengyuan, et al.
Publicado: (2023)

Dapagliflozin Ameliorates Diabetic Kidney Disease via Upregulating Crry and Alleviating Complement Over-activation in db/db Mice
por: Chang, Dong-Yuan, et al.
Publicado: (2021)

Ferroptosis Enhanced Diabetic Renal Tubular Injury via HIF-1α/HO-1 Pathway in db/db Mice
por: Feng, Xiaomeng, et al.
Publicado: (2021)

Fecal Transplantation from db/db Mice Treated with Sodium Butyrate Attenuates Ischemic Stroke Injury
por: Wang, Huidi, et al.
Publicado: (2021)

SGLT2 Inhibitor Empagliflozin and DPP4 Inhibitor Linagliptin Reactivate Glomerular Autophagy in db/db Mice, a Model of Type 2 Diabetes
por: Korbut, Anton I., et al.
Publicado: (2020)

Single-Cell Sequencing Analysis of the db/db Mouse Hippocampus Reveals Cell-Type-Specific Insights Into the Pathobiology of Diabetes-Associated Cognitive Dysfunction
por: Ma, Shizhan, et al.
Publicado: (2022)

Impacts of Diabetes and an SGLT2 Inhibitor on the Glomerular Number and Volume in db/db Mice, as Estimated by Synchrotron Radiation Micro-CT at SPring-8
por: Takiyama, Yumi, et al.
Publicado: (2018)

Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice
por: Gallo, Linda A., et al.
Publicado: (2016)

Acarbose ameliorates spontaneous type-2 diabetes in db/db mice by inhibiting PDX-1 methylation
por: Zhou, Diyi, et al.
Publicado: (2021)

Erratum: Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice
por: Gallo, Linda A., et al.
Publicado: (2016)

Debuncher DB1 (DB2 and DB3): 1 A06 - 000 - 1
por: Boltezar, E
Publicado: (1970)

Debuncher DB1 (DB2 and DB3): I A06-000-1
por: Boltezar, E
Publicado: (1970)

Antihyperglycemic and Antiobesity Effects of JAL2 on db/db Mice
por: Lee, In-Seung, et al.
Publicado: (2016)

Cosmos DB for MongoDB developers: migrating to Azure Cosmos DB and using the MongoDB API
por: Sharma, Manish
Publicado: (2018)

DB2 essentials: understanding DB2 in a big data world
por: Chong, Raul F, et al.
Publicado: (2013)

Effect of the sodium–glucose cotransporter 2 inhibitor luseogliflozin on pancreatic beta cell mass in db/db mice of different ages
por: Takahashi, Kiyohiko, et al.
Publicado: (2018)

Sodium Meta-Arsenite Ameliorates Hyperglycemia in Obese Diabetic db/db Mice by Inhibition of Hepatic Gluconeogenesis
por: Lee, Young-Sun, et al.
Publicado: (2014)

Efficacy and safety of dapagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in diabetes mellitus
por: Fioretto, Paola, et al.
Publicado: (2015)

SGLT-2-inhibition with dapagliflozin reduces tissue sodium content: a randomised controlled trial
por: Karg, M. V., et al.
Publicado: (2018)

A novel contrast-induced acute kidney injury mouse model based on low-osmolar contrast medium
por: Wu, Jiajia, et al.
Publicado: (2022)

Gut Microbiota Composition and Structure of the Ob/Ob and Db/Db Mice
por: Yang, Mingsheng, et al.
Publicado: (2019)

The sodium-glucose cotransporter 2 inhibitor luseogliflozin can suppress muscle atrophy in Db/Db mice by suppressing the expression of foxo1
por: Okamura, Takuro, et al.
Publicado: (2019)

Transcriptional Profile of Kidney from Type 2 Diabetic db/db Mice
por: Zhang, Haojun, et al.
Publicado: (2017)

Metformin accelerates wound healing in type 2 diabetic db/db mice
por: Han, Xue, et al.
Publicado: (2017)

Antidiabetic and Cardioprotective Effects of Pharmacological Inhibition of GRK2 in db/db Mice
por: Cipolletta, Ersilia, et al.
Publicado: (2019)

Abnormal gut microbiota composition contributes to the development of type 2 diabetes mellitus in db/db mice
por: Yu, Fan, et al.
Publicado: (2019)

Oleuropein Ameliorates Advanced Stage of Type 2 Diabetes in db/db Mice by Regulating Gut Microbiota
por: Zheng, Shujuan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rasdibdldphl3nf1k5s2p6jlbt